Clinical Trials in Seattle

Showing 4121-4140 of 7,135 trials

ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer

NCT00959959

The purpose of this study is to determine whether TOK-001 is safe and shows biological effect in the treatment of castration resistant prostate cancer (CRPC).

Prostate Cancer

LTN PHARMACEUTICALS, INC.49 participantsStarted Oct 2009

Los Angeles, California, United States • San Bernardino, California, United States • Baltimore, Maryland, United States +5 more locations

COMPLETEDPhase 3< 1 mile

MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers

NCT00563394

224 adults with diabetic foot ulcers will be randomized to either magainin peptide (MSI-78) or ofloxacin (FLOXIN, Ortho-McNeil Pharmaceutical Corporation) an oral fluoroquinolone antibiotic.

Diabetic Foot Ulcers

Abeona Therapeutics, Inc584 participantsStarted Aug 1994

Seattle, Washington, United States

COMPLETEDPhase 3< 1 mile

Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure

NCT03036124

The purpose of this study is to evaluate the effect of dapagliflozin on the incidence of worsening heart failure or cardiovascular death in patients with chronic heart failure with reduced ejection fraction

Chronic Heart Failure With Reduced Ejection Fraction (HFrEF)

AstraZeneca4,744 participantsStarted Feb 2017

Fairhope, Alabama, United States • Mobile, Alabama, United States • Sheffield, Alabama, United States +416 more locations

ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer

MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers

Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure

Find Trials by Condition in Seattle

Safety and Efficacy Study of EPI-743 in Children With Leigh Syndrome

AMG 827 in Subjects With Psoriatic Arthritis

Study of Endorectal Cooling During RARP to Minimize Trauma and Promote Earlier Return to Continence

A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung

Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis

Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer

Study of Rapastinel as Monotherapy in Patients With MDD

Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression

LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris

Resynchronization for Ambulatory Heart Failure Trial - LV Endocardial

An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids

A Study of CK-2127107 in Patients With Spinal Muscular Atrophy

Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor

Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis

Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia A

Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies

Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration